The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Microneedles permit transdermal delivery of a skin-impermeant medication to humans
Open accessAbstract
Drugs with poor oral bioavailability usually are administered by hypodermic injection, which causes pain, poor patient compliance, the need for trained personnel, and risk of infectious disease transmission. Transdermal (TD) delivery provides an excellent alternative, but the barrier of skin's outer stratum corneum (SC) prevents delivery of most drugs. Micrometer-scale microneedles (MNs) have been used to pierce animal and human cadaver skin and thereby enable TD delivery of small molecules, proteins, DNA, and vaccines for systemic action. Here, we present a clinical study of MN-enhanced delivery of a medication to humans. Naltrexone (NTX) is a potent mu-opioid receptor antagonist used to treat opiate and alcohol dependence. This hydrophilic and skin-impermeant molecule was delivered from a TD patch to healthy human subjects with and without pretreatment of the skin with MNs. Whereas delivery from a standard NTX TD patch over a 72-h period yielded undetectable drug plasma levels, pretreatment of skin with MNs achieved steady-state plasma concentrations within 2 h of patch application and were maintained for at least 48 h. The MNs and NTX patch were well tolerated with mild systemic and application site side effects. The MN arrays were painless upon administration and not damaged during skin insertion, and no MNs were broken off into the skin. This human proof-of-concept study demonstrates systemic administration of a hydrophilic medication by MN-enhanced TD delivery. These findings set the stage for future human studies of skin-impermeant medications and biopharmaceuticals for clinical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930
Williams, A. C., & Barry, B. W. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.025 · Cited by 1,746
Microneedles for transdermal drug delivery
Prausnitz, M. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.023 · Cited by 1,521
Self-citationThe Molecular and Cellular Biology of Wound Repair
(1988) · Springer eBooks · doi:10.1007/978-1-4615-1795-5 · Cited by 1,516
Current status and future potential of transdermal drug delivery
Prausnitz, M. R., Mitragotri, S., & Langer, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1304 · Cited by 1,462
Self-citationMcAllister, D. V., Wang, P. M., Davis, S. P., Park, J.-H., Canatella, P. J., Allen, M. G., & Prausnitz, M. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2331316100 · Cited by 859 · cited 2×
“For example, an array of stainless steel, solid MNs produces a grid of holes, or micropores, through which medications delivered via a standard patch, may be delivered to the skin for local or systemic drug absorption (9).”
BackgroundSelf-citationCoated microneedles for transdermal delivery
Gill, H. S., & Prausnitz, M. R. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.017 · Cited by 765
Self-citationThe molecular and cellular biology of wound repair
Naylor, I. (1996) · British Journal of Plastic Surgery · doi:10.1016/s0007-1226(96)90047-8 · Cited by 667
Lack of Pain Associated with Microfabricated Microneedles
Kaushik, S., Hord, A. H., Denson, D. D., McAllister, D. V., Smitra, S., Allen, M. G., & Prausnitz, M. R. (2001) · Anesthesia & Analgesia · doi:10.1097/00000539-200102000-00041 · Cited by 576
Self-citationSilicon micromachined hollow microneedles for transdermal liquid transport
Gardeniers, H. J. G. E., Luttge, R., Berenschot, E. J. W., de Boer, M. J., Yeshurun, S. Y., Hefetz, M., van-t Oever, R., & van den Berg, A. (2003) · Journal of Microelectromechanical Systems · doi:10.1109/jmems.2003.820293 · Cited by 413
Mikszta, J. A., Alarcon, J. B., Brittingham, J. M., Sutter, D. E., Pettis, R. J., & Harvey, N. G. (2002) · Nature Medicine · doi:10.1038/nm0402-415 · Cited by 398
Transdermal delivery of desmopressin using a coated microneedle array patch system
Cormier, M., Johnson, B. L., Ameri, M., Nyam, K., LIBIRAN, L., Zhang, D. D., & Daddona, P. E. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.003 · Cited by 388
Naltrexone: Disposition, metabolism, and effects after acute and chronic dosing
Verebey, K., Volavka, J., Mule, S. J., & Resnick, R. B. (1976) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1976203315 · Cited by 270
Mechanism of fluid infusion during microneedle insertion and retraction
Martanto, W., Moore, J. S., Couse, T., & Prausnitz, M. R. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.017 · Cited by 250
Self-citationClinical microneedle injection of methyl nicotinate: stratum corneum penetration
Sivamani, R. K., Stoeber, B., Wu, G. C., Zhai, H., Liepmann, D., & Maibach, H. (2005) · Skin Research and Technology · doi:10.1111/j.1600-0846.2005.00107.x · Cited by 171
Asbill, C. S., & Bumgarner, G. W. (2007) · doi:10.1002/9780470259818.ch21 · Cited by 153
Cross, S. E., & Roberts, M. S. (2004) · Current Drug Delivery · doi:10.2174/1567201043480045 · Cited by 152
Self-dissolving microneedles for the percutaneous absorption of EPO in mice
Ιtο, Y., Yoshimitsu, J., Shiroyama, K., Sugioka, N., & Takada, K. (2006) · Journal of drug targeting · doi:10.1080/10611860600785080 · Cited by 142
Microsystems for Drug and Gene Delivery
Reed, M., & Lye, W.-K. (2004) · Proceedings of the IEEE · doi:10.1109/jproc.2003.820542 · Cited by 116
Metabolism and disposition of naltrexone in man after oral and intravenous administration.
Wall, M. E., Brine, D. R., & Perez‐Reyes, M. (1981) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06161-6 · Cited by 112
(2003) · CRC Press eBooks · doi:10.1201/9781420040142.ch6 · Cited by 106
Karande, P., Jain, A., & Mitragotri, S. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.001 · Cited by 85
Donovan, D. M., Anton, R. F., Miller, W. R., Longabaugh, R., Hosking, J. D., & Youngblood, M. (2008) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2008.69.5 · Cited by 83
Naltrexone Biotransformation and Incidence of Subjective Side Effects: A Preliminary Study
King, A. C., Volpicelli, J. R., Gunduz, M., O’Brien, C. P., & Kreek, M. J. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1997.tb03856.x · Cited by 72
Enhancement of transdermal delivery of 6-β-naltrexol via a codrug linked to hydroxybupropion
Kiptoo, P. K., Hamad, M. O., Crooks, P. A., & Stinchcomb, A. L. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.003 · Cited by 46
Self-citationHuman Skin Permeation of Branched-Chain 3-O-Alkyl Ester and Carbonate Prodrugs of Naltrexone
Vaddi, H. K., Hamad, M. O., Chen, J., Banks, S. L., Crooks, P. A., & Stinchcomb, A. L. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-2592-9 · Cited by 35
Self-citationPharmacokinetics of Long‐Acting Naltrexone in Subjects With Mild to Moderate Hepatic Impairment
Turncliff, R. Z., Dunbar, J., Dong, Q., Silverman, B. L., Ehrich, E. W., Dilzer, S. C., & Lasseter, K. C. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005280199 · Cited by 29
Valiveti, S., Nalluri, B. N., Hammell, D. C., Paudel, K. S., & Stinchcomb, A. L. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.08.016 · Cited by 25
Self-citation
Cited by
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,517
Self-citationMicroneedles for drug and vaccine delivery
Kim, Y.-C., Park, J.-H., & Prausnitz, M. R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.04.005 · Cited by 1,760
Self-citationLarrañeta, E., Lutton, R. E. M., Woolfson, A. D., & Donnelly, R. F. (2016) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2016.03.001 · Cited by 964
Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety
Donnelly, R. F., Singh, T. R. R., & Woolfson, A. D. (2010) · Drug Delivery · doi:10.3109/10717541003667798 · Cited by 708
Microneedle technologies for (trans)dermal drug and vaccine delivery
van der Maaden, K., Jiskoot, W., & Bouwstra, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.042 · Cited by 651
Metadata
- Authors
- Wermeling, D. P., Banks, S. L., Hudson, D. A., Gill, H. S., Gupta, J., Prausnitz, M. R., & Stinchcomb, A. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-02-12
- Volume
- 105
- Issue
- 6
- Pages
- 2058-2063
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2141517515
- Cited by
- 311
- References
- 28
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.